For the Quarter Ending June 2026
Ìý
Azithromycin Prices in North America
- In USA, the Azithromycin Price Index rose by 0.35% quarter-over-quarter, marginal supply-demand balance, freight pressure.
- The average Azithromycin price for the quarter was approximately USD 143120.00/MT, reported by importers domestically.
- Azithromycin Spot Price activity reflected steady arrivals and modest buying, keeping the Price Index contained.
- Azithromycin Production Cost Trend rose from higher fermentation-media and container freight, supporting firmer CFR levels.
- Azithromycin Demand Outlook remains seasonally muted, distributor stock drawdowns supported steady spot enquiries and restocking.
- Azithromycin Price Forecast indicates modest recovery as procurement resumes and monsoon transit risks influence buying.
- Four-month inventories cushioned supply, while Indian export volumes and Chinese offers shaped Azithromycin Price Index.
- Major Indian plants operated normally, batch-release delays tightened availability and elevated Azithromycin Spot Price sensitivity.
Why did the price of Azithromycin change in June 2026 in North America?
- Firm Indian export offers and higher fermentation-media costs nudged CFR levels upward, tightening pass-through dynamics.
- US distributors reduced winter stocks, sustaining spot enquiries despite seasonal lull and supporting price recovery.
- Container freight increases and batch-release timelines at Indian plants elevated costs, influencing CFR import pricing.
Ìý
Azithromycin Prices in APAC
- In China, the Azithromycin Price Index rose by 0.28% quarter-over-quarter, reflecting balanced supply and steady export demand.
- The average Azithromycin price for the quarter was approximately USD 142900.00/MT, reflecting steady export and domestic procurement.
- Chinese exporters held firm offers; Azithromycin Spot Price movement remained restrained by abundant off-season warehouse inventory levels.
- Supply discipline and intermediate constraints shape the Azithromycin Production Cost Trend, supporting marginally firmer supplier pricing structures.
- Export inquiry pickup and seasonal tendering underpin the Azithromycin Demand Outlook for Q3, tightening prompt availability globally.
- Market commentary aligns with the Azithromycin Price Forecast indicating modest oscillations as buyers balance inventories and contracts.
- Improved solvent recovery efficiencies offset higher steam tariffs, moderating Azithromycin Production Cost Trend pressure marginally on exporters.
- Inventory at plant warehouses remained balanced, so the Azithromycin Price Index showed limited volatility across export lanes.
Why did the price of Azithromycin change in June 2026 in APAC?
- Constrained erythromycin intermediate availability from environmental checks tightened inputs, slightly elevating Azithromycin production costs and supplier offers.
- Mild seasonal fermentation yield dips reduced immediate output, limiting export spot volumes and supporting firmer FOB quotations.
- Export inquiry pickup from India, Nigeria and Brazil absorbed available stock, nudging the Azithromycin Price Index upward.
India
- In India, Azithromycin Price Index rose by 4.55% quarter-over-quarter, driven by higher erythromycin base costs.
- Azithromycin Spot Price eased as Chinese discounted exports returned, increasing availability and pressuring Vapi offers.
Ìý
Azithromycin Prices in Europe
- In Germany, the Azithromycin Price Index rose by 0.31% quarter-over-quarter, reflecting balanced imports and firmer export offers.
- The average Azithromycin price for the quarter was approximately USD 143043.33/MT, CFR Hamburg, reflecting stable procurement.
- Azithromycin Spot Price remained subdued as ample Indian and Chinese cargoes limited sellers' bargaining power in Hamburg.
- Azithromycin Production Cost Trend showed limited passthrough as freight, energy, and solvent costs remained stable.
- Azithromycin Demand Outlook remained neutral with hospital tenders and steady outpatient prescriptions capping upside for immediate procurement.
- Azithromycin Price Forecast anticipates volatility as seasonal demand, export availability, and port congestion influence CFR levels.
- Inventories in Hamburg hovered at normal cover, and rebuilding by wholesalers supported firmer landed price settlements.
- Indian and Chinese API plants operated routinely; sporadic audits trimmed immediate availability, tightening prompt offers slightly.
Why did the price of Azithromycin change in June 2026 in Europe?
- Port congestion and terminal delays in Hamburg reduced availability, increasing landed costs and buyer urgency.
- Firmer export offers from Indian macrolide producers after environmental audits tightened supply windows for shipments.
- Wholesalers rebuilt safety stocks ahead of summer holidays, increasing near-term prompt buying despite subdued consumption.
For the Quarter Ending March 2026
Ìý
Azithromycin Prices inÌýAPAC
- In China, the Azithromycin Price Index rose by 1.27% quarter-over-quarter, reflecting modestly firm export inquiries.
- The average Azithromycin price for the quarter was approximately USD 142500/MT, reflecting narrow trading range.
- Azithromycin Spot Price traded tightly as integrated plants sustained runs and exporters prioritized contract commitments.
- Azithromycin Price Forecast indicates upward bias driven by steady export demand and constrained smaller output.
- Azithromycin Production Cost Trend stayed stable as erythromycin feedstock and solvents remained readily available throughout.
- Azithromycin Demand Outlook remains export-led with India, Nigeria and Brazil driving incremental offtake and tightness.
- Azithromycin Price Index movements reflected limited inventory at ports and disciplined selling by coastal firms.
- Integrated Zhejiang and Jiangsu plants operated routinely, continuous-flow adopters improved yields, offsetting minor energy rises.
Why did the price of Azithromycin change in March 2026 in APAC?
- Reduced erythromycin fermentation broth availability tightened effective capacity, lengthening reaction cycles and trimming aggregate output.
- Firm export inquiries from India, Nigeria and Brazil increased offtake, supporting FOB Shanghai price appreciation.
- Domestic hospital tenders remained steady, and no major shutdowns prevented shortages, keeping market tone neutral.
Ìý
Azithromycin Prices inÌýEurope
- In Germany, the Azithromycin Price Index rose by 1.28% quarter-over-quarter, driven by tighter import availability.
- The average Azithromycin price for the quarter was approximately USD 142606.67/MT, based on CFR Hamburg arrival statistics.
- Azithromycin Spot Price tightened as Indian production adjustments reduced monthly shipments, supporting firmer landed quotations.
- Azithromycin Price Forecast indicates mild upward trajectory driven by steady procurement and constrained export allocations.
- Azithromycin Production Cost Trend rose slightly as environmental compliance upgrades increased manufacturing overheads across Asia.
- Azithromycin Demand Outlook remains stable with seasonal respiratory prescribing sustaining routine procurement by wholesalers domestically.
- Azithromycin Price Index reflected balanced inventories and steady Hamburg arrivals, preventing acute spot-price volatility overall.
- Export allocations tightened after mid-March retrofit work, elevating war-risk insurance costs and strengthening sellers margins.
Why did the price of Azithromycin change in March 2026 in Europe?
- Scheduled Indian effluent upgrades reduced bulk shipments, shrinking immediate supply and tightening landed availability levels.
- German wholesalers accelerated forward buying ahead of tender cycles, increasing demand and drawing down inventories.
- Higher environmental compliance costs and war-risk insurance premiums pushed landed costs upward, reducing downward pressure.
Ìý
Azithromycin Prices inÌýNorth America
- In the USA, the Azithromycin Price Index rose by 1.27% quarter-over-quarter, reflecting steady import demand.
- The average Azithromycin price for the quarter was approximately USD 142626.67/MT across New York shipments.
- Azithromycin Spot Price remained constrained as distributors replenished three-to-five month safety stocks, preserving short-term premiums.
- Azithromycin Price Forecast projects mild upward movement as formulators continue routine restocking and demand steadies.
- Azithromycin Production Cost Trend showed steady fermentation expenses, while side-chain intermediate pressures increased manufacturer offers.
- Azithromycin Demand Outlook remains firm seasonally, supporting contractual lifting by finished-dose manufacturers and distributor restocking.
- Azithromycin Price Index momentum reflected concentrated Asian supply, disciplined exporter releases and port discharge schedules.
- Higher trucking charges raised delivered costs, prompting distributors to accept firmer offers as inventories normalized.
Why did the price of Azithromycin change in March 2026 in North America?
- Concentrated Asian production and export allocations tightened immediate availability, allowing sellers to push higher quotes.
- Elevated intermediate costs and trucking charges raised delivered costs, contributing upward pressure on CIF values.
- Distributors replenished three-to-five month safety stocks amid steady prescriptions, reducing spot availability and supporting increases.
For the Quarter Ending DecemberÌý2025
Ìý
AzithromycinÌýDihydrate Price in APAC
- In China, the Azithromycin Dihydrate Price Index rose by 0.13% quarter-over-quarter, reflecting modest cost pressures.
- The average Azithromycin Dihydrate price for the quarter was approximately USD 140713.33/MT, reflecting stable FOB.
- Azithromycin Dihydrate Spot Price eased in late December as overseas enquiries slowed and exporters discounted.
- Azithromycin Dihydrate Price Forecast indicates mild recovery potential once year-end destocking and restocking cycles normalize.
- Azithromycin Dihydrate Production Cost Trend showed increases from logistics premiums and intermittent intermediate material surcharges.
- Azithromycin Dihydrate Demand Outlook remains broadly muted internationally while domestic tenders support baseline consumption levels.
- Inventory builds pressured the Azithromycin Dihydrate Price Index, prompting exporters to prioritise volume over margin.
- Coastal manufacturers ran at routine rates; continuous-flow units improved yields, sustaining shipments despite softer exports.
Why did the price of Azithromycin DihydrateÌýDihydrate change in December 2025 in APAC?
- Weaker overseas buying reduced export enquiry volumes, increasing downward pressure on FOB offers and shipments.
- VAT rebate timing and logistics delays temporarily compressed margins, prompting producers to discount late-month shipments.
- Inventories built at coastal warehouses encouraged aggressive selling, while domestic tenders kept incremental demand minimal.
Ìý
AzithromycinÌýDihydrate Price in Europe
- In Germany, the Azithromycin Dihydrate Price Index rose by 0.78% quarter-over-quarter, supported by restocking and logistics constraints.
- The average Azithromycin Dihydrate price for the quarter was approximately USD 145148.33/MT, reflecting steady import parity dynamics.
- Azithromycin Dihydrate Spot Price remained pressured as competitive Indian offers and ample exports limited distributor urgency.
- AzithromycinÌýDihydrate Price Forecast indicates modest gains into early 2026 driven by seasonal demand and year-end hedging activity.
- AzithromycinÌýDihydrate Production Cost Trend shows lower upstream raw material costs offset by rising logistics and compliance expenses.
- AzithromycinÌýDihydrate Demand Outlook strengthened seasonally as respiratory infection upticks increased prescriptions, prompting distributors to rebuild safety inventories.
- AzithromycinÌýDihydrate Price Index momentum softened in December as ample shipments and tender pressures produced downward price adjustments.
Why did the price of AzithromycinÌýDihydrateÌýchange in December 2025 in Europe?
- Soft Indian export offers increased available supply, pressuring landed costs and reducing German replacement bidding activity.
- Antimicrobial stewardship and tendering restrained procurement, limiting distributor restocking and suppressing stronger AzithromycinÌýDihydrate demand during December.
- Hamburg logistics remained fluid while currency movements were neutral, allowing lower dollar offers to pass through.
Ìý
AzithromycinÌýDihydrate Price in North America
- In USA, the AzithromycinÌýDihydrate Price Index rose by 0.79% quarter-over-quarter, due to logistics and restocking.
- The average AzithromycinÌýDihydrate price for the quarter was approximately USD 145193.33/MT based on import totals and CFR New York transactions.
- AzithromycinÌýDihydrate Spot Price eased as improved cargo arrivals and distributors reduced spot purchases, normalizing inventories.
- AzithromycinÌý Dihydrate Price Forecast indicates increases into early 2026 driven by seasonal procurement and freight costs.
- AzithromycinÌýDihydrate Production Cost Trend stable, Indian manufacturers operated normally while upstream intermediate costs remained contained.
- AzithromycinÌýDihydrate Demand Outlook remains moderate with seasonal prescription increases offset by stewardship programs and options.
- AzithromycinÌýDihydrate Price Index volatility limited as distributors ran down buffer stocks and CFR pricing softened.
- Indian export flows and Chinese intermediate supply supported availability while CFR New York margins pressured.
Why did the price of AzithromycinÌýDihydrateÌýchange in December 2025 in North America?
- Ocean transits normalized and cargos arrived on schedule, increasing port inventories and relieving immediate scarcity pressures.
- Distributor inventories remained comfortable, reducing spot purchases and applying downward pressure on landed AzithromycinÌýDihydrate prices.
- Seasonal demand rose but stewardship protocols and new therapies limited additional macrolide procurement, moderating price upside.
For the Quarter Ending September 2025
North America
- In the USA, the Azithromycin Price Index rose by 0.57% quarter-over-quarter, reflecting restocking after destocking.
- The average Azithromycin price for the quarter was approximately USD 144060/MT, reported by surveyed participants.
- Azithromycin Spot Price volatility eased as logistics costs corrected and destocking pressures at distributors abated.
- Azithromycin Price Forecast signals modest upward drift as buyers restock ahead of anticipated year-end disruptions.
- Azithromycin Production Cost Trend remained stable as manufacturers absorbed moderate freight and input cost increases.
- Azithromycin Demand Outlook shows muted seasonal uptake with buyer caution and inventory normalization limiting procurement.
- Azithromycin Price Index remained rangebound while import surges and port delays produced regional price spikes.
- Inventories normalized across distributors, export demand softened, and major U.S. suppliers maintained stable operational utilization.
Why did the price of Azithromycin change in September 2025 in North America?
- Anticipatory stockpiling earlier in quarter reduced buying needs, sustaining downward pressure into September 2025 market.
- Logistics cost corrections and easing freight rates lowered landed costs, discouraging urgency for new purchases.
- Weaker consumer and business sentiment constrained downstream orders, prompting distributors to liquidate excess inventory instead.
APAC
- In China, the Azithromycin Price Index rose by 0.59% quarter-over-quarter in Q3 2025, reflecting recovery.
- The average Azithromycin price for the quarter was approximately USD 143916.67/MT, reported FOB Shanghai terms.
- Azithromycin Spot Price remained pressured by abundant export supply and subdued buying interest in June.
- Azithromycin Price Forecast shows modest recovery as restocking and improved demand slightly tighten export availability.
- Azithromycin Production Cost Trend eased as freight fell and input prices softened, relieving margin pressure.
- Azithromycin Demand Outlook remains cautious as western buyers delay purchases, maintaining subdued spot transaction volumes.
- Elevated inventories and weaker export demand pressured the Azithromycin Price Index, encouraging competitive seller offers.
- Some exporters curtailed output cycles during summer disruptions, tightening near-term availability and supporting price gains.
Why did the price of Azithromycin change in September 2025 in APAC?
- Supply overhang and accumulated inventories reduced seller pricing power, weakening export demand, pressuring spot markets.
- Falling freight and softer input prices reduced production costs, increasing buyer leverage and lowering offers.
- Cautious international procurement and tariff uncertainties delayed restocking, keeping demand outlook subdued and prices restrained.
Europe
- In Germany, the Azithromycin Price Index rose by 0.603% quarter-over-quarter, reflecting recovery from logistics disruptions.
- The average Azithromycin price for the quarter was approximately USD 144020.00/MT, confirmed by distributors nationwide.
- Tightened shipping windows elevated the Azithromycin Spot Price volatility, pressuring distributors to secure cargo quickly.
- Forward curves and clearance improvements shaped the Azithromycin Price Forecast suggesting gradual normalization over months.
- Stable raw material feedstocks kept the Azithromycin Production Cost Trend subdued, limiting pressure on margins.
- Domestic healthcare procurement and export demand supported the Azithromycin Demand Outlook, though buyers remained cautious.
- Elevated distributor stocks and deferred orders depressed volumes while the Azithromycin Price Index edged higher.
- Port congestion, Rhine barge constraints and seasonal restocking combined to tighten supply and raise bids.
Why did the price of Azithromycin change in September 2025 in Europe?
- Persistent port congestion and river transport constraints delayed shipments, reducing available immediate supply into German markets.
- Rising freight surcharges and rerouting increased landed costs and incentivized buyers to accelerate orders, pressuring spot availability.
- High distributor inventories earlier in quarter moderated price rises, but seasonal restocking reversed that trend during September.